- Report
- October 2024
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 96 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- June 2024
- 161 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- June 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 152 Pages
Global
From €2757EUR$2,900USD£2,316GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- January 2025
- 201 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2024
- 500 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- December 2024
- 130 Pages
Global
From €2842EUR$2,990USD£2,388GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 167 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2025
- 240 Pages
Global
From €2557EUR$2,690USD£2,148GBP
- Report
- March 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more